Hydroxyurea Capsules USP
Resistant chronic myelotic leukemia.
Recurrent,Metastatic or inoperable carcinoma of the ovary.
Primary squamous cell(epidermal) carcinomas of the head and the neck cancer, excluding the lip.
ADULTS : Initial doses is 150 mg/m2 once daily for 5 consecutive days per 25 days treatment.
INTERMITTENT THERAPY : 80mg/kg administered orally as a single dose every third day.
CONTINUOUS THERAPY : 20 to 30 mg/kg administered orally as a single dose daily.
Dosage Adjustment :
Renal Impairment : Required.
Hepatic Impairment : Administer with caution.
We are also dealing in:
|Name of the Product||Composition|
|Unidrea 500mg Capsules.||Hydroxyurea 500mg|